PATENT CLAIM ANALYSIS

Application Number: 16013856
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "449000"]

Abstract:
A modular transdermal drug delivery system is provided, the system including: an upper module in which an outer backing layer is laminated to a pressure-sensitive adhesive layer that is covered by a removable release liner prior to assembly; and a lower module with a porous drug reservoir layer laminated to a skin-contact adhesive that affixes the system to the skin during drug delivery, where the skin-contact adhesive is, in one embodiment, an adhesive layer that is substantially co-extensive with the porous drug reservoir layer and, prior to use, protected with a second removable release liner. Methods of manufacture and use are also provided, as is an assembled transdermal drug delivery system fabricated by affixing the pressure-sensitive adhesive layer of the upper module to the porous drug reservoir layer of the lower module.

Claim (Index 77):
The method of  claim 76 , wherein the cannabinoid is selected from tetrahydrocannabinol (THC), dronabinol, cannabichromanone, cannabichromene (CBC), cannabichromenic acid, cannabichromevarin (CBCV), cannabichromevarinic acid, cannabicitran (CBT), cannabicoumaronone (CBCON), cannabicyclol (CBL), cannabicyclolic acid, cannabicyclovarin, cannabidiol (CBD), cannabidiol monomethyl ether, dimethyl heptylpentyl cannabidiol (DMHP-CBD), cannabidiolic acid, cannabidiorcol, cannabidivarin (CBV), cannabidivarinic acid, cannabielsoin (CBE), cannabielsoinic acid, cannabifuran, cannabigerol (CBG), cannabigerol monomethyl ether (CBGM), cannabigerolic acid, cannabigerolic acid monomethyl ether, cannabigerovarin (CBGV), cannabigerovarinic acid, cannabiglendol, cannabinodiol, cannabinodivarin, cannabinol (CBN), cannabinolic acid, cannabinol methyl ether, cannabiorcol, cannabiripsol, cannabitetrol, cannabitriol, 10-O-ethyl-cannabitriol, cannabivarichromene, cannabivarin, dehydrocannabifuran, 1,2-dihydroxyhexahydrocannabinol, 1,2-dihydroxyhexahydrocannabinol acetate, dimethylheptylpyran, isotetrahydrocannabivarin, levonantradol, nabilone, rimonabant, \u0394 9 -tetrahydrocannabinolic acid, \u0394 9 -tetrahydrocannabiorcol, \u0394 9 -tetrahydrocannabiorcolic acid, \u0394 9 -tetrahydrocannabivarin, \u0394 9 -tetrahydrocannabivarinic acid, 8,11-dihydroxy-\u0394 9 -tetrahydrocannabinol, 8,9-dihydroxy-\u0394 6a,10a -tetrahydrocannabinol, \u0394 8 -tetrahydrocannabinol, \u0394 8 -isotetrahydrocannabinol, \u0394 8 -tetrahydrocannabinolic acid, 10-oxo-\u0394 6a,10a -tetrahydrocannabinol (OTHC), HU-210 (1,1-dimethylheptyl-11-hydroxy-\u0394 8 -THC), HU-331 (3-hydroxy-2-[(1R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone), JWH-018 (1-pentyl-3-(1-naphthoyl)indole), JWH-073, AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole), and CP-55,940 (2-((1S,2S,5 S)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl)-5-(2-methyloctan-2-yl)phenol).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 2.34426
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12979978', '11245106', '10631539', '14851764', '15221673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7536341290353866
- 35 USC 102 Novelty (BERT): 0.498797968863768
- Combined Prediction Score: 0.7281505130182248
- Mean Citation Score: 243.980958
- Max Citation Score: 252.26967
- Similarity Product: 190.0437219829309

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test